Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05540704 · ClinicalTrials.gov registry record · NA
Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes
A NA study of Type 1 Diabetes and Binge-Eating Disorder, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 235
- Enrollment target
- 2
- Study locations
NCT05540704 is a NA study of Type 1 Diabetes and Binge-Eating Disorder that is actively recruiting participants, run by Duke University. The registered enrollment target is 235 participants, below the 823-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (71% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05540704, a NA study of Type 1 Diabetes and Binge-Eating Disorder, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 235 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to test whether a new intervention works to treat eating disorders in type 1 diabetes. Participants are assigned to one of the following: (1) Acceptance and Commitment Therapy (ACT), (2) Supportive Diabetes Counseling, or (3) a 6-month Waitlist Control. Participants in the ACT and Supportive Diabetes Counseling conditions complete 12 sessions over 12-16 weeks and use their mobile phone between sessions to increase engagement and reinforce learning. The main questions are: Does treatment improve glycemic levels, eating disorder symptoms, diabetes management and diabetes distress? Does one treatment do better than the other? How do the treatments work, if they work, and for whom? Participants complete assessments that include wearing a continuous glucose sensor and activity watch, and get a blood draw to determine HbA1c. They also complete diagnostic interviews, surveys and computer tests of attention and things like heart rate and reaction time. These assessments help us better understand the types of changes that are happening and how they might influence health and well-being.
Conditions Studied
Interventions
- BEHAVIORAL ACT
- BEHAVIORAL Supportive Diabetes Counseling
Study Locations (2)
North Carolina
- Duke University - Durham
Rhode Island
- Brown University - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 235 participants |
| Start Date | 2023-04-04 |
| Est. Completion | 2027-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05540704
The ClinicalTrials.gov registry entry for NCT05540704 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 235 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 823-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (71% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which ACT is the first listed.
NCT05540704 reports 2 study locations spanning 2 distinct geographic areas - top geographies include North Carolina, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT05540704 about?
NCT05540704 is a clinical study titled "Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes". The goal of this clinical trial is to test whether a new intervention works to treat eating disorders in type 1 diabetes. Participants are assigned to one of the following: (1) Acceptance and Commitment Therapy (ACT), (2) Supportive Diabetes Counseling, or (3) a 6-month Waitlist Control. Participant...
What is the current status of trial NCT05540704?
This trial is currently recruiting. It is a NA study. The enrollment target is 235 participants. The study started on 2023-04-04. Estimated completion is 2027-09.
What conditions does trial NCT05540704 study?
This clinical trial studies the following conditions: Type 1 Diabetes, Binge-Eating Disorder, Eating Disorders, Purging (Eating Disorders), Disordered Eating Behaviors.
What interventions are being tested in trial NCT05540704?
The interventions under investigation include: ACT (BEHAVIORAL), Supportive Diabetes Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT05540704?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05540704 being conducted?
This trial has 2 study locations across North Carolina, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
REAL-Fam Feasibility Study for Youth Diabetes Management
RECRUITING · NA
-
AIDANET Pediatrics
RECRUITING · NA
-
A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery
RECRUITING · NA
-
EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.